Analysis of a T-cell antigen receptor (TCR) a promoter from a variable gene segment (V) revealed a critical GT box element which is also found in upstream regions of several Va genes, TCR enhancer, and regulatory elements of other genes. This element is necessary for TCR gene expression and binds several proteins. These GT box-binding proteins were identified as members of a novel Spl multigene family. Two regions (for reviews, see references 5 and 27). The process of V-D-J gene rearrangements is developmentally and tissue specifically regulated. The TCR a and 8 genes are particularly interesting because the 8 locus is located within the TCR a-gene segments. In T cells committed to the a,3 lineage, the a-specific V-gene segments are rearranged to the a locus, whereas in cells committed to the -yb lineage, the b-specific V-gene segments are rearranged to their respective D/Jb gene segments. Some V gene segments, however, can rearrange to either the a or 8 locus (these gene segments are also called Va).
expression and function. The T-cell receptor is a heterodimeric protein composed of either a(x or yb subunits with which T 5 and 27) . The process of V-D-J gene rearrangements is developmentally and tissue specifically regulated. The TCR a and 8 genes are particularly interesting because the 8 locus is located within the TCR a-gene segments. In T cells committed to the a,3 lineage, the a-specific V-gene segments are rearranged to the a locus, whereas in cells committed to the -yb lineage, the b-specific V-gene segments are rearranged to their respective D/Jb gene segments. Some V gene segments, however, can rearrange to either the a or 8 locus (these gene segments are also called Va).
Studies using transgenic mice and cell lines suggest that specific gene segment transcription correlates with differential accessibility of each locus to the recombinase during development (8, 7) . Production of sterile transcripts from unrearranged gene segments, in particular, has been found to precede gene rearrangement. It is hypothesized that sterile transcription is either the cause or the consequence of differential opening of chromatin structure and hence accessibility of the gene segment to the recombination enzymes (references 7 and 28 and references therein). Since each of the V-gene segments contains its own promoter, it is possible that the specificity of sterile transcription from these V promoters could contribute to differential accessibility to recombinases during T-cell development, which could result in specific gene segment usage in aot and/or 9y T cells (35) . * Corresponding author.
Therefore, the study of TCR a promoters can serve the dual purpose of analyzing TCR gene expression as well as regulation of rearrangement.
We have focused on the well-characterized Vall.1 gene segment, which is the gene segment predominantly used in T-cell response to pigeon cytochrome c (9, 38) . We have analyzed the critical elements for the Vall.1 promoter and found one element which we called the GT box. This GT box is also present in most other available Va upstream sequences (presumably promoters) as well as in the TCR ax enhancer. Homologous regulatory elements (AC boxes) were previously defined in the ,-globin enhancers, promoters, and locus-controlling region (LCR) as well as in the bovine papillomavirus (BPV) promoters and simian virus (SV40) enhancer. This novel element for T-cell gene expression was shown to bind ubiquitously expressed proteins, one of which was identified as the transcription factor Spl (18) . Although Spl is one of the earliest-characterized transcription factors which also binds to a consensus GC box sequence, we have made the assumption that additional GT box-binding proteins contain sequence homology to the Spl DNA-binding domain. We have isolated two novel Splrelated genes, which we call Sp2 and Sp3. Sequence analysis of the Sp2 and Sp3 cDNA clones predicts that they encode proteins with several transactivation domains and a Zn finger DNA-binding domain with extensive homology to Spl. Their in vitro-produced proteins also bind to the GT box. Hence, Spl, Sp2, and Sp3 constitute a novel Spl multigene family with similar characteristics which can presumably regulate a wide variety of genes in different tissues. Furthermore, the existence of proteins similar to Spl indicates that gene regulation by Spl is more complicated than previously assumed.
MATERUILS AND METHODS
Plasmid construction and transfection. The Vall.1 promoter region was obtained by using a limited genomic library from the T-cell hybridoma AN6.2 reactive for cytochrome c as described previously (38) .
Plasmid pCATMoEnT was constructed in three steps. (36) . pTCR1700MoEn was made by inserting the SalI-SmaI Moloney enhancer fragment of pUCMoEn into XhoI-EcoRV sites of plasmid pTCR1700.
The following plasmids were made in pCATMoEnT:
pTCR25OMoEnT, pTCR15OMoEnT, pVa2C47OMoEnT, and pVa2C24OMoEnT. For pTCR25OMoEnT and pTCR15OMo
EnT, a blunt-ended BstNI-SmaI fragment and a PvuII-SmaI fragment of pTCR35OMoEn (=pTCR65OMoEn) containing the Vall.1 promoter sequences were used (pTCR350MoEn/ pTCR65OMoEn is similar to pTCR1700MoEn, with the 5' end extending to PstI site only). For the Va2C promoter (10), a 470-bp StyI fragment and a 240-bp BglII-StyI fragment from the Va2C promoter region were blunt ended with Klenow enzyme and cloned into the SmaI site of plasmid pCATMoEnT to generate pVa 2C470MoEnT and pVa2 C24OMoEnT, respectively.
The start of Vall.1 transcription was estimated by RNase protection. For this purpose, a BstNI-XbaI fragment of plasmid pTCR1700 was cloned into the SmaI site plasmid pSP72 (pTCR1700 was made by inserting SmaI-HindIII fragment of 18pTCR11 into the corresponding sites of pCAT). The plasmid was linearized with EcoRI, and an SP6 transcript was generated. As a marker, a Maxam-Gilbert G sequencing reaction was performed on a PvuII-XbaI fragment of plasmid pTCR1700. Plasmids J21 and J21MoEn containing a minimal c-fos promoter have been described before (36) . Transfection into various cell lines and subsequent assays for CAT activity were performed as described elsewhere (34) .
Heteroduplex mutagenesis. Heteroduplex oligonucleotidemediated mutagenesis was performed in double-stranded plasmid DNA as described previously (22) . The GT box sequence GCAGAGGTGGGTGGAGTTTCG in plasmid pTCR25OMoEnT was changed to GCAGAGG1TI'TGGAG TTTCG to generate plasmids mut-1 and mut-2. Mutant plasmids were screened with a mutant oligonucleotide at high stringency and confirmed by DNA sequencing (mut-1 is identical to mut-2). For gel mobility shift assays of GT box-binding protein, oligonucleotides VAl (TCGAGAG GTGGGTGGAGTTTCGCG) and VA2 (TCGACGCGAAA CTCCACCCACCTC) were annealed and labeled with Klenow enzyme. For the mutant GT box oligonucleotides, 2 bp of the GGTGGGTGG sequences in VAl were changed to GG1T[GTGG (mVA2). The corresponding sequences in the VA2 oligonucleotide were also changed (mVA3). The two mutant oligonucleotides were then annealed and used in gel mobility shift experiments.
Gel shift analysis and methylation interference. Gel shift assays were performed as described previously (30, 33) , using 0.5 x Tris-borate buffer. Methylation interference analyses were performed as described elsewhere (29, 30) . For purified Spl protein, binding to the GC box was facilitated by the inclusion of 0.1% Nonidet P-40 and 0.1 mg of bovine serum albumin (BSA) per ml in the binding reaction mixtures (14) . Nonidet P-40 and BSA were not needed, however, for Spl produced by in vitro translation. Purified human Spl protein from HeLa cells infected with recombinant vaccinia virus containing a full-length Spl cDNA was purchased from Promega. For the Spl consensus probe (GC box), the two complementary oligonucleotides corresponding to the sequence ATTCGATCGGGGCGGGGCGAGC (Promega) were kinase treated and used in the gel mobility shift assay. For the GT box binding reaction, the buffer consisted of 10 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES)-KOH (pH 7.9), 50 mM NaCl, 5 mM Tris-HCl (pH 7.5), 15 mM EDTA, 1 mM dithiothreitol, and 5% glycerol. For competition studies, the following subclones were generated for the different Va promoters: Vall.1 (BstNI-PvuII fragment into PvuII of pSP72), Va2C (EcoRI-BamHI fragment into the corresponding sites in pSP72) (pSP72Va2C), VaBDFL1 (BamHI-KpnI fragment into BamHI-KpnI sites of pSP72) (pSP72-BDFLI), and VaSH (HindIII fragment into HindIII site of pUC8). For nonspecific competition, oligonucleotides 12RSS-A (GATCCCACGTGCTCCAGGGCTG AACAAAAACCGA) and 12RSS-B (GATCTCGGTITTTG TTCAGCCCTGGAGCACTGTGG) were used.
Cloning, in vitro transcription and translation, and gel shift. For cloning of Sp2 and Sp3, a human T-cell library (HUT78 plus phorbol myristate acetate) was screened at low stringency, using the NcoI fragment containing the Spl Zn finger. Washes were performed at 50°C in 2x SSC (lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate) for low-stringency conditions and at 65°C in 0.1 x SSC for high-stringency conditions. Two clones, S1 and S13, corresponding to Sp2 and Sp3, respectively, were obtained. Both were subcloned into pSP72 vector (Promega). To obtain a full-length Sp2 clone, another T-cell cDNA library from Moltl3 (constructed in Xgtll) was screened. A clone containing a 2.7-kb insert, S1/7, was obtained and subcloned into pBluescript II-KS(-) vector (Stratagene). In vitro transcription and translation were performed as suggested by the manufacturer (Promega). Northern (RNA) blotting was performed by using Si and S13 inserts as probes as described previously (24 Fig. 1 and data not shown). This result is consistent with the notion that the TCR promoter alone is very weak and is activated by the enhancer located near the constant region after rearrangement has taken place. When a heterologous enhancer from the Moloney murine virus long terminal repeat was added to the 3' end of the constructs (pTCR1700MoEn and pTCR35OMoEnT), however, CAT activity could be detected in all T-cell lines examined (Jurkat, YAC-1, and ELA; Fig. 1 and unpublished result) . For all the experiments, a c-fos promoter and Moloney virus enhancer construct (J21MoEn) which works in all cell lines was used as a positive control, and a promoterless Moloney virus enhancer construct was used as a negative control (pCATMoEnT). The minimal functional promoter elements (pTCR250 MoEnT in Fig. 1 ) were found within 130 bp 5' of the major RNA initiation site, as determined by an RNase protection experiment ( Fig. 2A ). An essential promoter element was further localized to an 88-bp fragment (-130 to -42), since deletion of the corresponding DNA resulted in a completely inactive promoter (Fig. 1, pTCR15OMoEnT ).
Sequence analysis of this minimal Va promoter region did not reveal a TATA box, GC-rich region, or initiator consensus sequence (YYCAYYYYY [31] [26] ), and the BPV regulatory elements (23) (Fig. 2B ). In addition, the element is found in the TCR a enhancer (_100 bp 3' of the GATA3 site in the mouse genome and =60 and 100 bp 3' of the GATA3 site in the human genome; Fig. 2B ).
GT box-binding proteins. To identify the protein(s) regulating the activity of the TCR a promoter, we performed DNase I footprint analysis with the minimal promoter region. No DNase I-protected regions, however, were found (33a). As an alternate approach, a gel shift assay using the minimal 88-bp BstNI-PvuII fragment as a probe was performed. One major retarded protein-DNA band was found in a variety of nuclear extracts from human and mouse lymphoid cell lines (ETA, Jurkat, Moltl3, Peer T cell, S194, 38B9, 22D6, and BJA-B B cell) and nonlymphoid cell lines (L cells and HeLa; arrow in Fig. 3 ). The protein-DNA interaction is specific, as the complex could be competed away with 50-and 100-fold excesses of specific probe (Fig. 3 , lanes 3 and 4) but not with an equivalent amount of nonspecific DNA (lanes 5 and 6). Additional complexes were found in nuclear extracts of human origin; these complexes, however, are probably nonspecific protein-DNA complexes, as they cannot be competed for with a 400-fold excess of a specific DNA fragment (19a) . The protein-binding site was identified by methylation interference and localized to the conserved GT box spanning positions -48 to -64 of the Vall.1 promoter (Fig. 4) . The same methylation interference pattern was seen with use of nuclear extracts from T cells of either human or mouse origin (Jurkat or ELA, respectively). Hence, we have identified a protein complex which binds to the conserved GT box of the TCR a promoters.
As discussed above, homology to the GT box was found in human and mouse TCR a enhancers and two other Va upstream sequences at positions similar to that of the GT box in the Vall.1 promoter. This homology is significant because competition studies performed in gel shift experiments indicated that the GT box DNA-protein complex can be competed for with an excess of DNA fragments from the TCR a enhancer, Va (23, 32) . To probe the relationship between Spl and the GT box-binding proteins, we performed gel shift analysis under several conditions, using purified Spl protein and crude nuclear extracts containing GT box-binding proteins. Purified Spl protein can indeed bind to the GT box. However, the methylation interference pattern with use of purified Spl and the Va promoter fragment is different from that of nuclear extracts (Fig. 4) . Upon further analysis using a small GT box oligonucleotide as a probe, two DNA-protein complexes could be resolved in all cell lines tested (Fig. 5) . The relationship between Spl and the GT box proteins from the nuclear extracts was further investigated by using a monoclonal antibody against human Spl generated with peptide sequences immediately outside the Spl Zn finger (14 domain. Therefore, the human Spl Zn finger domain was used as a probe to screen a human HUT78 (a,B T cells) cDNA library under low-stringency conditions. More than 20 positive clones were found, but most of these were Spl since they retained the hybridized signal after repeated stringent washes. Two of the clones (S1 and S13), however, lost their hybridization signal to the Spl Zn finger after stringent washing, indicating that they are homologous but not identical to Spl. These two clones were chosen for further analysis as putative cDNAs encoding GT box-binding proteins. The original S1 clone was not full length, as revealed by its inability to produce in vitro-translated protein and by its small insert size. A full-length version of S1 (S1/7)
was then isolated from a human Moltl3 (yb T cells) cDNA library and characterized. Sequencing analysis of the two clones revealed that S1/7 and S13 are indeed two separate genes which constitute a novel Spl gene family ( Fig. 6 and  7) . We propose the names Sp2 and Sp3 for these two genes to reflect this fact. The Sp2 cDNA contains an open reading frame of 495 amino acids (Fig. 6 ). The translation initiation site was assigned on the basis of homology to Kozak sequences and on the assumption that it starts with a methionine. The assignment, however, is still tentative, as the reading frame is open to the extreme 5' end of the cDNA clone for another 118 amino acids and other nonmethionine codons can be used in some rare occasions. The Sp3 cDNA contains an open reading frame of 713 amino acids (Fig. 7) . Assignment of the translation initiation site for Sp3 is particularly difficult because no AUG codon can be found in the first 218 amino acids of the reading frame. Assignment of AUG as the start codon predicts a short polypeptide of 494 amino acids. By using the in vitro-translated product, the size of Sp3 was estimated at close to 100 kDa (see below). Furthermore, extensive homology to Spl can be detected in the first 218 amino acids of the open reading frame preceding the AUG codon; hence, it is very unlikely that Sp3 translation starts at the AUG at nucleotide 653. Several non-AUG start sites have previously been identified for mammalian genes (21, 39) . Sp3 translation could initiate at AUU at nucleotide 183 and GUG at nucleotide 291. The translation initiation site of Sp3 was tentatively assigned to AUU starting at nucleotide 183, for a predicted polypeptide of 653 amino acids.
The protein structures of Sp2 and Sp3 are very similar to that of Spl. All of them contain three Zn fingers with the structure Cys2-His2. Homology to Spl at the Zn finger domain is 72% for Sp2 and 90% for Sp3 (Fig. 8) throughout the entire open reading frame, whereas homology outside the Zn finger domain for Sp2 is much more limited. Interestingly, both Sp2 and Sp3 also contain transactivation domains with characteristics similar to those of the Spl domains (Fig. 9) . The Sp3 protein also shares with Spl the glutamine-rich domains A and B, while the Sp2 protein contains only one glutamine-rich region. All three proteins also contain a highly charged protein domain, C, located immediately 5' of the zinc fingers and a serine/ threonine-rich region. The Sp3 but not Sp2 protein contains a sequence homologous to the domain D sequence, which is located at the C-terminal end of the Spl protein. Hence, the Sp2 protein has a serine/threonine-rich region followed by a glutamine-rich domain (domain B), a highly charged domain (domain C), and three Zn fingers. The structure of the Sp3 protein, on the other hand, is strikingly similar to that of Spl, with two homologous glutamine-rich regions, a serine/threonine-rich region, a highly charged domain, three zinc fingers, and a C-terminal domain similar to the Spl domain D (Fig. 9) . (Fig. 9) . Hence, all three members of the Spl family, Spl, Sp2, and Sp3, are similar in their DNA-binding domains and transactivation domains as well as in their ubiquitous expression.
GCGGCCGCCGTAATGAGCGATCCACAGACC AGCATGGCTGCCACTGCTGCTGTGAGTCCC AGTGACTACCTGCAGCCTGCCGCCTCCACC ACCCAGGACTCCCAGCCATCTCCCTTAGCC CTGCTTGCTGCAACATGTAGCAAAATTGGC CCTCCAGCAGTTGAAGCTGCTGTGACACCT CCTGCTCCCCCACAGCCCACACCGCGGAAA CTTGTCCCTATCAAACCTGCCCCTCTCCCT CTCAGCCCCGGCAAGAATAGCTTTGGAATC TTGTCCTCCAAAGGAAATATACTTCAGATT CAGGGGTCACAACTGAGCGCCTCCTATCCT GGAGGGCAGCTGGTGTTCGCTATCCAGAAT CCCACCATGATCAACAAAGGGACCCGATCA AATGCCAATATCCAGTACCAGGCGGTCCCT CAGATTCAGGCAAGCAATTCCCAAACCATC M I N K G T R S N A N I Q Y Q A V P Q I Q A S N S Q T I> CAAGTACAGCCCAATCTCACCAACCAGATC CAGATCATCCCTGGCACCAACCAAGCCATC ATCACCCCCTCACCGTCCAGTCACAAGCCT Q V Q P N L T N Q I Q I I P G T N Q A I I T P S P S S H K P> GTCCCCATCAAGCCAGCCCCCATCCAGAAG TCGAGTACGACCACCACCCCCGTGCAGAGC GGGGCCAATGTGGTGAAGCTGACAGGTGGG V P I K P A P I Q K S S T T T T P V Q S
G A N V V K L T G G> GGCGGCAATGTGACGCTCACTCTGCCCGTC AACAACCTTGTGAACGCCAGTGACACCGGG GCCCCTACTCAGCTCCTCACTGAAAGCCCC G G N V T L T L P V N N L V N A S D T G A P T Q L L T E S P> CCAACCCCGCTGTCTAAGACTAACAAGAAA GCAAGGAAGAAGAGCCTTCCTGCCTCCCAG CCCCCTGTGGCTGTGGCTGAGCAGGTGGAG P T P L S K T N K K A R K K S L P A S Q P P V A V A E Q V E> ACGGTGCTGATCGAGACCACCGCGGACAAC ATCATCCAGGCAGGAAATAACCTGCTCATT GTTCAGAGCCCTGGTGGGGGCCAGCCAGCT T V L I E T T A D N I I Q A G N N L L I V Q S P G G G Q P A> GTGGTCCAGCAGGTCCAGGTGGTGCCCCCC AAGGCCGAGCAGCAGCAGGTGGTACAGATC CCCCAGCAGGCTCTGCGGGTGGTGCAGGCG V V Q Q V Q V V P P K A E Q Q Q V V Q I P Q Q A L R V V Q A> GCATCTGCCACCCTCCCCACTGTACCCCAG AAGCCCTCCCAGAACTTTCAGATCCAGGCA GCTGAGCCGACACCTACTCAGGTCTACATC A
S A T L P T V P Q K P S Q N F Q I Q A A E P T P T Q V Y I> CGCACGCCTTCCGGTGAGGTGCAGACAGTC CTTGTCCAGGACAGCCCCCCAGCAACAGCT GCAGCCACCTCTAACACCACCTGTAGCAGC R T P S G E V Q T V L V Q D S P P A T A A A T S N T T C S S> CCTGCATCCCGTGCTCCCCATCTGAGTGGG ACCAGCAAAAAGCACTCAGCTGCAATTCTC CGAAAAGAGCGTCCCCTGCCAAAGATTGCC P A S R A P H L S G T S K K H S A A I L R K E R P L P K I A> CCAGCCGGGAGCATCATCAGCCTGAATGCA GCCCAGTTGGCGGCAGCTGCCCAGGCAATG CAGACCATCAACATCAATGGTGTCCAGGTC P A G S I I S L N A A Q L A A A A Q A M Q T I N I N G V Q V>
CAGGGCGTGCCTGTCACCATCACCAACACA GGCGGGCAGCAGCAGCTGACAGTGCAGAAT GTTTCTGGGAACAACCTGACCATCAGTGGG 7 . DNA and predicted amino acid sequences of the S13 cDNA clone (Sp3).
Sp2 and Sp3 encode GT box-binding proteins. To investigate the DNA-binding activities of the Sp2 and Sp3 proteins, both S1/7 and S13 cDNAs were subcloned into an pSP72 vector (Promega) which contains SP6 and T7 RNA promoters for in vitro transcription. In vitro transcription and translation of both the S1/7 and S13 clones were first performed in the presence of [35S]methionine to test whether Sp2 and Sp3 proteins could be translated in vitro without an artificial AUG start codon. Consistent with the notion that both S1/7 and S13 clones are full length, the in vitrotranslated products yielded an Sp2 protein of approximately 80 kDa and an Sp3 protein of approximately 100 kDa (Fig.   lla) . Smaller species also found in the gel are presumably minor degradation products of the full-length proteins.
To test the DNA-binding activities of Sp2 and Sp3 proteins, in vitro translation reactions in the absence of any radioactivity were performed, and the products were used in a gel shift experiment using either the 88-bp Vall.1 promoter fragment or the small GT box oligonucleotide as a probe. As controls, we included Spl protein translated in vitro and the rabbit reticulocyte lysate alone, without any exogenous RNA added (Fig. llb, lanes 1 and 4) . Sp2 protein binds to the Vctll.1 promoter fragment, although weakly (lane 3). The Sp3 protein, however, binds with affinity comparable to that of Spl to both the Vall.1 promoter fragment (lane 3) and the GT box oligonucleotide (lanes 5 to 9). The binding is specific, as revealed by competition studies using specific and nonspecific competitors (lanes 5 to 9). As expected from differences in predicted amino acid sequence between Spl and Sp3, the Sp3 protein binding activities cannot be abolished or supershifted with a mono- LG.P. clonal antibody against Spl (lanes 10 to 13). Hence, both Sp2 and Sp3 proteins can bind to the GT box motif of the T-cell receptor Vall.1 promoter region.
As Sp3 protein binds to the GT box of the TCR Vall.1 promoter with high affinity, it might regulate the promoter activity. Indeed, a preliminary experiment indicated that Sp3 can transactivate the Vall.1 GT box element in a Drosophila cell line (19a) . This notion is further supported by the fact that the Sp3-GT box oligonucleotide complex comigrates with the second band of the GT box protein complex detected in the nuclear extracts (arrows in Fig. 12 ). Indeed, the purified Spl-GT box complex migrates slower than the Sp3-GT box complex, and each complex comigrates with one of the bands detected in nuclear extracts. This occurs with use of either the GT box or the Spl consensus se- quence, the GC box, as a probe (Fig. 12) . Hence, other than a slight shift in migration pattern, no discernible differences in DNA-binding activity can be detected between Spl and the newly characterized Sp3 gene, whereas the Sp2 protein binds weakly to the TCR Va GT box and not at all to the GC box (data not shown).
DISCUSSION
We have analyzed the T-cell-specific TCR Vall.1 promoter and narrowed its activity to a 130-bp DNA sequence. Analysis of the minimal promoter region revealed a transcriptional element which we termed the GT box. The GT box is a crucial element for TCR a-promoter activity, and it binds to ubiquitously expressed proteins. noglobulin heavy-chain gene promoters. All of the TCR promoters contain a conserved and essential element homologous to the CRE (cyclic AMP-responsive element)/AP1 site (1, 2) , and all of the immunoglobulin heavy-chain promoters contain the Oct element (reference 33 and references therein). This diversity in the Va gene families might reflect the unique organization of the TCR a/8 locus (27) . The 8 locus is located within the TCR a-gene segments, and rearrangement as well as transcription of different a and 8 gene segments are highly regulated. In T cells committed to the ao lineage, the a-specific V-gene segments are rearranged to the respective D/Jb gene segments. Some V-gene segments, however, can rearrange to either the a or 8 locus. As each V-gene segment contains its own promoter at the 5' upstream region, it is possible that different specificities of sterile transcription from these V-gene promoters could contribute to differences in accessibility to recombinases during T-cell development. This could result in distinct but overlapping gene segment usage in a,B and -yb T cells (35) . We showed that the three Va gene segments analyzed from the Val, -6, and -11 families contain GT box-binding sites and that one from the Va3 family (Va2C) does not have the GT box in its functional promoter region. Interestingly, members of the Val, -6, and -11 gene families have been found to rearrange to both a and 8 genes, whereas members of the Va3 family have thus far never been found in -yb T cells (17) . Hence Sp3 is most likely the second Vall.1 GT box-binding protein detected in nuclear extracts because in gel shift experiments, the DNA-Sp3 protein complex comigrates with the DNA-protein complex from nuclear extract. Sp3 mRNA is also expressed widely, and the in vitro-translated product binds to the GT box element of the TCR promoter with high affinity, consistent with characteristics of the GT box-binding proteins from nuclear extracts. Furthermore, preliminary experiments indicated that Sp3 can transactivate the Vall.1 GT box in a Drosophila cell line (19a) . The Sp2 protein, on the other hand, binds to the GT box in the TCR promoter very weakly. Because flanking sequences might affect binding affinity, Sp2 might bind to other GT box motifs which regulate other genes. More interestingly, Sp3 binds to the Spl consensus sequence GC box as well, although both Sp3 and Spl bind to the GT box with higher affinity. The striking similarity between Spl and Sp3 raises the interesting issue of whether an activity attributed to Spl in many previous studies might actually be due to the Sp3 protein. It also raises a more general issue of how gene regulation by two very similar factors is actually achieved in vivo.
The GT box is also present in the human and mouse TCR a enhancers (13, 36) . There are two GT boxes in the human a enhancer at approximately 60 and 100 bp 3' from the GATA3-binding site (12, 16, 20, 24) and one in the mouse enhancer 100 bp away from the GATA3-binding site. Although the GT box is located outside the original minimal enhancer fragment as defined by transient transfection experiments, it might reflect redundancy in enhancer function or it might have another function in TCR a gene regulation (e.g., serving as an LCR). Redundancy in the TCR a enhancer was demonstrated by experiments deleting one of the a enhancer protein-binding site (CRE = Tal). Deletion of the Tal site in the minimal a enhancer resulted in VOL. 12, 1992 abrogation of the enhancer activity, whereas a similar deletion on a larger piece of the enhancer had a negligible effect (the larger enhancer fragment includes the GT box as well as an additional protein-binding site, Ta4 [11] ). A possible function of the GT box as an LCR was previously suggested for the 3-globin LCR (16; for a review of the globin system, see reference 25). The GT box (=AC box) is present in all four DNase I-hypersensitive sites which constitute the P-globin LCR. In addition, the GT box is also found in a-and s-globin promoters and ,B-globin enhancer (see reference 26
and references therein). The minimal 225-bp fragment containing HSS2 of the ,3-globin LCR in particular (26) contains four GT box-binding sites as well as several GATA-binding sites. GATA-and GT-binding sites are common features of many erythroid cell-specific regulatory elements. It was proposed that interactions of erythroid-specific GATAl-and GT box-binding proteins are a key component of the LCR activity in erythroid cells (26) . As similar GATA and GT box elements are also found in the TCR at enhancer, the interaction of T-cell-specific GATA3 protein and members of the Spl multigene family might play a key role in any possible T-cell-specific LCR function. Finally, GC and GT boxes are found in regulatory elements of other genes as well, including the human immunodeficiency virus long terminal repeat (15), SV40 enhancer (39) , and BPV promoters (23, 32) .
Hence, this novel Spl multigene family might regulate a wide variety of viral and cellular genes in different tissues.
